The S&P 500 is back within spitting distance of an all-time high, and this time Big Tech isn’t leading the rebound.

Eli Lilly and Company (LLY) is a global pharmaceutical leader focused on discovering, developing, and commercializing ...

This was the stock's fifth consecutive day of losses.

The possibility of adding a new Big Tech customer helped lift an American chipmaker's stock on Friday, Nov. 28, 2025, while a ...

Healthcare is the only one of the S&P 500's 11 sectors that is showing weakness on the day, with the Health Care Select ...

Let’s delve into the details of each of the evaluated factors, but first, for a quick background: With a $917 Bil market cap, Eli Lilly offers pharmaceuticals globally, focusing on treatments for ...

Live Updates Get The Best Amazon Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Amazon, market updates, and brand-new stock recommendations delivered ...

S&P 500 heads for weakest November since 2021 as AI fears hit stocks; Albemarle and Eli Lilly surge while Super Micro and ...

The S&P 500 closed near its Oct. 28 record, buoyed by optimism that the Federal Reserve could cut interest rates next month.

S&P 500 fell 0.2% and the Nasdaq dropped 0.8%, extending Thursdays rout, while the Dow rose 0.3% with a 133-point gain.

Eli Lilly & Co, Cardinal Health Inc and Biogen Inc are among the top 10 performers in the S&P 500 since Oct 28, the last time ...

Shares of Eli Lilly & Co. slipped 2.61% to $1,075.47 Friday, on what proved to be an all-around positive trading session for ...